2nd June 2005

COBALZ today announced that Dr Andrew McCaddon will present clinical data relating to the combined use of N-acetylcysteine and cobalamin at the 5th International Homocysteine Conference in Milan later this month

His presentation will detail clinical improvements found after co-administering N-acetylcysteine, vitamin B12 and folate in cognitively impaired hyperhomocysteinaemic patients

These promising initial findings are being formally evaluated in a randomized controlled clinical trial (COBALZ IV) conducted by researchers based at the University of Texas (for further details see related news item "US License issued")